Skip to main content
MedPathMedPath Home
Clinical Trials/CTRI/2018/05/013946
CTRI/2018/05/013946
Completed
未知

Markers For Early Risk-Stratification Of Gestational Diabetes (MERGD)�: A Prospective Cohort Study - MERGD

ata Medical Research Foundation0 sites1,041 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
ConditionsHealth Condition 1: null- Pregnant Women

Overview

Phase
未知
Intervention
Not specified
Conditions
Health Condition 1: null- Pregnant Women
Sponsor
ata Medical Research Foundation
Enrollment
1041
Status
Completed
Last Updated
3 years ago
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
3 years ago
Study Type
Observational

Investigators

Sponsor
ata Medical Research Foundation

Eligibility Criteria

Inclusion Criteria

  • •1\.If the candidate woman has come to antenatal care before 20 weeks of gestation
  • •2\. Those who have consented

Exclusion Criteria

  • •1\.If the candidate woman has come to antenatal care after 20 weeks of gestation
  • •2\. Those who have not consented

Outcomes

Primary Outcomes

Not specified

Similar Trials

Completed
Not Applicable
Identification of the risk factors of the fetal infection in pregnant women with chronic/past CMV infectiocongenital cytomegalovirus infection
JPRN-UMIN000021527Department of Obstetrics and Gynecology Kobe University Graduate School of Medicine600
Completed
Not Applicable
Analysis of risk factors in early pregnancy to predict pregnancy complications and complications in these women later in lifeintrauterine growth restrictionpreeclampsia1001108210026908
NL-OMON30528Medisch Centrum Haaglanden1,000
Not yet recruiting
Not Applicable
Measurement of Urinary Biomarkers in Urine to predict Kidney problems during Pregnancy in women with Pre-Eclampsia.
CTRI/2024/07/070289Post Graduate Institue of Medical Education and Research
Completed
Not Applicable
IMproved Pregnancy Outcomes by Early Detection; personalised medicine for pregnant women: novel metabolomic and proteomic biomarkers to detect pre-eclampsia and improve outcome.hypertension in pregnancytoxemia1002690810057166
NL-OMON40138niversity College Cork, Ireland1,000
Completed
Not Applicable
First-trimester maternal factors and biomarker screening for preeclampsia: Asia-wide study
JPRN-UMIN000030347Obstetrics and Gynecolgy, Toyama University Hospital2,000